Rad, PerkinElmer, Abcam and Enzo Life Sciences. Profiles cover cell-based assay products, technologies, applications, end users and trends.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Cell Based Assays ...

CellCarta and Imagene AI today announced an expanded collaboration to provide a coordinated path for biopharma companies to validate, deploy, and scale AI-powered biomarker and companion diagnostic ...

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide quick results while delivering expected performance and ...

Since biological therapeutics are derived from living organisms, their manufacture and validation presents difficulties not encountered during traditional small molecule drug development. Despite the ...

Lateral flow assays are an area of intense research and have led to highly robust and sensitive products, proving themselves indispensable for rapid diagnostics. Advancements in technologies used for ...

PCR assay development often involves separate steps for consumables, reagents, and instrumentation, making the path from prototype to production more complex. An integrated workflow connects these ...

A novel high-throughput screening assay is designed to identify inhibitors of the androgen receptor, which plays a critical role in the progression of prostate cancer. The assay could be used to ...

Biomarker discovery and research is a rapidly growing healthcare field that continues to impact the healthcare system significantly. Biomarker research has been used in preclinical research settings ...